| A Laboratory School Comparison of Mixed Amphetamine Salts Extended Release (Adderall XR®) and Atomoxetine (Strattera®) in school-aged children with attention deficit … SB Wigal, JJ McGough, JT McCracken, J Biederman, TJ Spencer, ... Journal of Attention Disorders 9 (1), 275-289, 2005 | 146 | 2005 |
| SLI381 (Adderall XR), a two‐component, extended‐release formulation of mixed amphetamine salts: bioavailability of three test formulations and comparison of fasted, fed, and … SJ Tulloch, Y Zhang, A McLean, KN Wolf, DA Mays Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 22 (11 …, 2002 | 57 | 2002 |
| 40 years of topical tretinoin use in review NJ Baldwin HE, Nighland M, Kendall C, Mays DA Journal of Drugs in Dermatology 12 (6), 638-42, 2013 | 42* | 2013 |
| A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in … J Biederman, SB Wigal, TJ Spencer, JJ McGough, DA Mays Clinical Therapeutics 28 (2), 280-293, 2006 | 36 | 2006 |
| Early inflammatory processes in the skin G N Stamatas, A P Morello, D A Mays Current molecular medicine 13 (8), 1250-1269, 2013 | 35 | 2013 |
| The safety of RhIG in the prevention of haemolytic disease of the newborn TG Hirose, DA Mays Journal of Obstetrics and Gynaecology 27 (6), 545-557, 2007 | 21 | 2007 |
| Quality of pharmacotherapy consultations provided by drug information centers in the United States KA Calis, DW Anderson, DA Auth, DA Mays, NM Turcasso, CC Meyer, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20 (7 …, 2000 | 18 | 2000 |
| Use of topical tretinoin and the development of noncutaneous adverse events: evidence from a systematic review of the literature S Shapiro, A Heremans, DA Mays, AL Martin, M Hernandez-Medina, ... Journal of the American Academy of Dermatology 65 (6), 1194-1201, 2011 | 15 | 2011 |
| Hard water softening effect of a baby cleanser RM Walters, E Anim-Danso, SM Amato, KA Capone, MC Mack, ... Clinical, Cosmetic and Investigational Dermatology, 339-345, 2016 | 14 | 2016 |
| Hypothyroidism associated with aminoglutethimide in patients with prostate cancer WD Figg, A Thibault, AO Sartor, D Mays, D Headlee, KA Calis, ... Archives of internal medicine 154 (9), 1023-1025, 1994 | 13 | 1994 |
| Analog classroom study of amphetamine XR and atomoxetine for ADHD S Wigal, J McGough, JT McCracken, T Clark, D Mays, S Tulloch 51st Annual Meeting of the American Academy of Child and Adolescent …, 2004 | 12 | 2004 |
| Human cumulative irritation tests of common preservatives used in personal care products: a retrospective analysis of over 45 000 subjects RM Walters, P Khanna, M Hamilton, DA Mays, L Telofski Toxicological Sciences 148 (1), 101-107, 2015 | 10 | 2015 |
| Safety and efficacy of MAS XR in adolescents with ADHD S Grcevich, SC Read, D Sea, DA Mays, SJ Tulloch Poster presented at the 51st Annual Meeting of the American Academy of Child …, 2004 | 9 | 2004 |
| SLI381. 404 Study Group.(2005). A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR®) and atomoxetine (Strattera®) in school-aged children … SB Wigal, TL Wigal, JJ McGough, JT McCracken, SH Kollins, J Biederman, ... Journal of Attention Disorders 9 (1), 275-289, 0 | 8 | |
| Methylphenidate transdermal system. DA Mays, R Findling Lippincott Williams & Wilkins, 2005 | 5 | 2005 |
| The effect of Adderall XR® treatment on driving performance in young adults with ADHD GG Kay, B Pakull, TM Clark, D Sea, DA Mays, SJ Tulloch Poster presented at the 17th Annual US Psychiatric & Mental Health Congress …, 2004 | 5 | 2004 |
| Long-term Adderall XR treatment improves quality of life in ADHD children FA Lopez, MC Chandler, J Biederman, T Spencer, DA Mays, MA Michaels, ... 156th Annual Meeting of the American Psychiatric Association, San Francisco …, 2003 | 4 | 2003 |
| A cohort analysis of measured growth parameters in children with attention-deficit hyperactivity disorder receiving mixed amphetamine salts (MAS XR) for 24 months\ TJ Spencer, SV Faraone, JA Morgan, DA Mays, MA Michaels, S Tulloch JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY 14 (4), 513-513, 2004 | 1 | 2004 |
| Pharmacokinetics of an extended-release formulation of mixed amphetamine salts (MAS XR) in adolescents with ADHD SW Boellner, DM Eades, WG Kramer, DA Mays, SC Read, SJ Tulloch JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY 14 (4), 514-514, 2004 | 1 | 2004 |
| Effects of amphetamine and methylphenidate on cytochrome P450 activity. CL DeVane, M Pennick, P Hodgins, DA Mays, C McDaniel, MA Michaels, ... PHARMACOTHERAPY 23 (10), 1359-1359, 2003 | 1 | 2003 |
